|
1
|
Ackerman LV: Verrucous carcinoma of the
oral cavity. Surgery. 23:670–678. 1948.PubMed/NCBI
|
|
2
|
Spiro RH: Verrucous carcinoma, then and
now. Am J Surg. 176:393–397. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Addante RR and McKenna SJ: Verrucous
carcinoma. Oral Maxillofac Surg Clin North Am. 18:513–519. 2006.
View Article : Google Scholar
|
|
4
|
Wray A and McGuirt WF: Smokeless tobacco
usage associated with oral carcinoma. Incidence, treatment,
outcome. Arch Otolaryngol Head Neck Surg. 119:929–933. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fliss DM, Noble-Topham SE, McLachlin M,
Freeman JL, Noyek AM, van Nostrand AW and Hartwick RW: Laryngeal
verrucous carcinoma: a clinicopathologic study and detection of
human papillomavirus using polymerase chain reaction. Laryngoscope.
104:146–152. 1994.
|
|
6
|
Mitsuishi T, Ohara K, Kawashima M,
Kobayashi S and Kawana S: Prevalence of human papillomavirus DNA
sequences in verrucous carcinoma of the lip: genomic and
therapeutic approaches. Cancer Lett. 222:139–143. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Walvekar RR, Chaukar DA, Deshpande MS, Pai
PS, Chaturvedi P, Kakade A, Kane SV and D’Cruz AK: Verrucous
carcinoma of the oral cavity: A clinical and pathological study of
101 cases. Oral Oncol. 45:47–51. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Horwitz J: α-crystallin. Exp Eye Res.
76:145–153. 2003.
|
|
9
|
Inagaki N, Hayashi T, Arimura T, Koga Y,
Takahashi M, Shibata H, Teraoka K, Chikamori T, Yamashina A and
Kimura A: αB-crystallin mutation in dilated cardiomyopathy. Biochem
Biophys Res Commun. 342:379–386. 2006.
|
|
10
|
Kumarapeli AR, Su H, Huang W, Tang M,
Zheng H, Horak KM, Li M and Wang X: αB-crystallin suppresses
pressure overload cardiac hypertrophy. Circ Res. 103:1473–1482.
2008.
|
|
11
|
Cherneva R, Petrov D, Georgiev O, Slavova
Y, Toncheva D, Stamenova M and Trifonova N: Expression profile of
the small heat-shock protein α-B-crystallin in operated-on
non-small-cell lung cancer patients: clinical implication. Eur J
Cardiothorac Surg. 37:44–50. 2010.
|
|
12
|
Holcakova J, Hernychova L, Bouchal P,
Brozkova K, Zaloudik J, Valik D, Nenutil R and Vojtesek B:
Identification of αB-crystallin, a biomarker of renal cell
carcinoma by SELDI-TOF MS. Int J Biol Markers. 23:48–53. 2008.
|
|
13
|
Tang Q, Liu YF, Zhu XJ, Li YH, Zhu J,
Zhang JP, Feng ZQ and Guan XH: Expression and prognostic
significance of the αB-crystallin gene in human hepatocellular
carcinoma. Hum Pathol. 40:300–305. 2009.
|
|
14
|
Chin D, Boyle GM, Williams RM, Ferguson K,
Pandeya N, Pedley J, Campbell CM, Theile DR, Parsons PG and Coman
WB: αB-crystallin, a new independent marker for poor prognosis in
head and neck cancer. Laryngoscope. 115:1239–1242. 2005.
|
|
15
|
Moyano JV, Evans JR, Chen F, Lu M, Werner
ME, Yehiely F, Diaz LK, Turbin D, Karaca G, Wiley E, Nielsen TO,
Perou CM and Cryns VL: αB-crystallin is a novel oncoprotein that
predicts poor clinical outcome in breast cancer. J Clin Invest.
16:261–270. 2006.
|
|
16
|
Shin JH, Kim SW, Lim CM, Jeong JY, Piao CS
and Lee JK: αB-crystallin suppresses oxidative stress-induced
astrocyte apoptosis by inhibiting caspase-3 activation. Neurosci
Res. 64:355–61. 2009.
|
|
17
|
Pindborg JJ, Reichart PA and Smith CJ:
Histological Typing of Cancer and Precancer of the Oral Mucosa. 2nd
edition. Springer-Verlag; Berlin: 1997, View Article : Google Scholar
|
|
18
|
Greene FL: American Cancer Society: AJCC
cancer staging manual. 6th edn. New York: American Joint Committee
on Cancer, Springer-Verlag; 2002
|
|
19
|
Masilamoni JG, Jesudason EP, Baben B,
Jebaraj CE, Dhandayuthapani S and Jayakumar R: Molecular chaperone
α-crystallin prevents detrimental effects of neuroinflammation.
Biochim Biophys Acta. 1762:284–293. 2006.
|
|
20
|
Tang Z, Xie X, Li J, Liu X, Yao Z and Zhao
S: A clinical study on oral verrucous carcinoma phenotypes. Chin J
Dent Res. 8:57–61. 2005.
|
|
21
|
Tang ZG, Zhao SP, Zhang L and Li XL: Gene
expression profile changes in oral verrucous carcinoma and oral
squamous cell carcinoma. Zhonghua Kou Qiang Yi Xue Za Zhi.
42:229–230. 2007.PubMed/NCBI
|
|
22
|
Hengartner MO: Apoptosis and the shape of
death. Dev Genet. 21:245–248. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kamradt MC, Chen F, Sam S and Cryns VL:
The small heat shock protein αB-crystallin negatively regulates
apoptosis during myogenic differentiation by inhibiting caspase-3
activation. J Biol Chem. 277:38731–38736. 2002.
|
|
24
|
Dimberg A, Rylova S, Dieterich LC, Olsson
AK, Schiller P, Wikner C, Bohman S, Botling J, Lukinius A,
Wawrousek EF and Claesson-Welsh L: αB-crystallin promotes tumor
angiogenesis by increasing vascular survival during tube
morphogenesis. Blood. 111:2015–2023. 2008.
|
